ArticleMolecular cancer2025

Targeting CXCR2 in prostate cancer cells can block CD47-SIRPα interaction and reverse M2 macrophage polarization in the TME.

Yi Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.